Dr. Foods, Inc.
DRFS · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.00 | 0.59 | -5.84 |
| FCF Yield | -3,650.75% | -3.56% | -1.89% | -3.98% |
| EV / EBITDA | 0.07 | -2.22 | -63.54 | -44.61 |
| Quality | ||||
| ROIC | 257.58% | 2,014.05% | -9.76% | -13.57% |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% |
| Cash Conversion Ratio | 0.93 | 0.08 | 1.20 | 1.82 |
| Growth | ||||
| Revenue 3-Year CAGR | 275,045.93% | 251,474.07% | 174.16% | -23.91% |
| Free Cash Flow Growth | -66.57% | 26.67% | 52.51% | -613.99% |
| Safety | ||||
| Net Debt / EBITDA | 0.10 | 0.02 | 0.18 | 0.51 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 94.27 | 319.54 | 231.47 | 476.28 |